Immunome (IMNM) Shares Issued (2023 - 2025)
Historic Shares Issued for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $45.5 million.
- Immunome's Shares Issued changed N/A to $45.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.2 million, marking a year-over-year decrease of 821.09%. This contributed to the annual value of $20.0 million for FY2024, which is 8400.0% down from last year.
- As of Q3 2025, Immunome's Shares Issued stood at $45.5 million.
- In the past 5 years, Immunome's Shares Issued ranged from a high of $125.0 million in Q2 2023 and a low of $34000.0 during Q1 2023
- In the last 3 years, Immunome's Shares Issued had a median value of $9.8 million in 2024 and averaged $31.6 million.
- Within the past 5 years, the most significant YoY rise in Immunome's Shares Issued was 997941.18% (2024), while the steepest drop was 9976.0% (2024).
- Immunome's Shares Issued (Quarter) stood at $64.0 million in 2023, then tumbled by 74.58% to $16.3 million in 2024, then skyrocketed by 179.48% to $45.5 million in 2025.
- Its Shares Issued was $45.5 million in Q3 2025, compared to $215000.0 in Q2 2025 and $213000.0 in Q1 2025.